Arthritic Therapeutic Market Forecast: How Big Will It Be by 2030?

Uncover key drivers, emerging technologies, and competitive movements shaping the arthritic therapeutic market from 2026–2035 with trusted insights from The Business Research Company

Starting from its 2026 valuation, what market size is the Arthritic Therapeutic Market expected to reach by 2030?

The market for arthritic therapeutics has experienced robust expansion in recent years. It is anticipated to increase from $72.44 billion in 2025 to $77 billion in 2026, achieving a compound annual growth rate (CAGR) of 6.3%. This historical growth can be attributed to the escalating global prevalence of arthritis, a growing geriatric population, restricted availability of advanced therapeutics, increasing awareness regarding arthritis management, and the expansion of hospital and clinic infrastructure.

The arthritic therapeutic market is anticipated to experience robust expansion over the coming years, with its size projected to reach $97.09 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 6.0%. This projected growth is attributable to several factors, including the emergence of new biologics and targeted treatments, the wider acceptance of telemedicine and remote patient monitoring, the incorporation of digital health platforms, increased funding for arthritis research and clinical trials, and the expansion of personalized medicine strategies for arthritis. Key trends expected during this period involve a growing uptake of biologic and targeted therapies for arthritis, a greater demand for customized arthritis management plans, an increase in home-based physical therapy and rehabilitation offerings, the proliferation of online pharmacies and digital distribution networks, and an enhanced emphasis on early diagnosis and preventative arthritis care.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19297&type=smp

What Drivers Are Driving Adoption Within The Arthritic Therapeutic Market?

The escalating occurrence of arthritis is anticipated to fuel the expansion of the arthritic therapeutic market. Arthritis refers to a collection of over 100 conditions primarily characterized by joint pain and inflammation. Its rising prevalence stems from an aging global population, increased obesity rates, and lifestyle elements that contribute to joint stress and inflammation. Arthritis treatments aim to alleviate symptoms, reduce inflammation, and enhance joint function, significantly improving the quality of life for affected individuals. For example, a June 2024 report from the Australian Institute of Health and Welfare, an Australia-based government organization, stated that approximately 514,000 people (2.0% of the population) were living with rheumatoid arthritis in 2022. Furthermore, rheumatoid arthritis comprised 2.0% of the total disease burden and accounted for 16% of the total burden for all musculoskeletal conditions in 2023. This demonstrates how the increasing incidence of arthritis is indeed driving the growth of the arthritic therapeutic market.

How Is The Arthritic Therapeutic Market Organized Into Various Segments?

The arthritic therapeutic market covered in this report is segmented –

1) By Drug Class: Tumor Necrosis Factor (TNF) Inhibitors, Interleukin Inhibitors, Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Corticosteroids, Xanthine Oxidase Inhibitors, Other Drug Classes

2) By Route Of Administration: Oral, Parenteral, Topical

3) By Type: Psoriatic Arthritis, Rheumatoid Arthritis, Osteoarthritis, Gout, Other Types

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Tumor Necrosis Factor (TNF) Inhibitors: Adalimumab, Etanercept, Infliximab, Certolizumab Pegol, Golimumab

2) By Interleukin Inhibitors: Interleukin-6 (IL-6) Inhibitors, Interleukin-1 (IL-1) Inhibitors, Interleukin-17 (IL-17) Inhibitors, Interleukin-23 (IL-23) Inhibitors

3) By Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Ibuprofen, Naproxen, Diclofenac, Celecoxib, Meloxicam

4) By Corticosteroids: Prednisone, Methylprednisolone, Hydrocortisone, Dexamethasone

5) By Xanthine Oxidase Inhibitors: Allopurinol, Febuxostat

6) By Other Drug Classes: Disease-Modifying Antirheumatic Drugs (DMARDs), Janus Kinase (JAK) Inhibitors, Biologic DMARDs, Topical Analgesics, Opioid Pain Medications

Which Market Trends Are Opening Growth Opportunities In The Arthritic Therapeutic Market?

Major companies operating within the arthritis therapeutic market are concentrating on developing advanced solutions, such as biosimilar monoclonal antibody-based therapies, to enhance the effectiveness of treatments and reduce costs. These biosimilar monoclonal antibody-based therapies are medical treatments specifically crafted to closely mimic and replicate the efficacy of original monoclonal antibodies, providing similar therapeutic benefits at a potentially lower price point. For instance, in May 2024, Bio-Thera Solutions Ltd., a China-based biopharmaceutical firm, introduced TOFIDENCE, an intravenous biosimilar monoclonal antibody formulation based on ACTEMRA. TOFIDENCE (tocilizumab-bavi) was developed as a biosimilar to the reference drug ACTEMRA and has received approval for treating moderately to severely active rheumatoid arthritis, polyarticular juvenile idiopathic arthritis, and systemic juvenile idiopathic arthritis.

Who Are The Prominent Global Companies Shaping The Arthritic Therapeutic Market Landscape?

Major companies operating in the arthritic therapeutic market are Pfizer Inc., Johnson & Johnson, Hoffmann-La Roche Ltd, Merck & Co Inc., AbbVie Inc., Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca Pharma AB, GlaxoSmithKline plc, Eli Lilly and Company, Amgen Inc., Gilead Sciences Inc., Regeneron Pharmaceuticals Inc., Astellas Pharma Inc., Biogen Inc., Vertex Pharmaceuticals Incorporated, Zimmer Biomet Holdings Inc., UCB Pharma S.A., Incyte Corporation, Celltrion Inc., Mallinckrodt Pharmaceuticals, Genentech Inc., Anika Therapeutics Inc., Medac GmbH

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/arthritic-therapeutic-global-market-report

Which Geographic Areas Are Emerging As Strong Markets For The Arthritic Therapeutic Market?

North America was the largest region in the arthritic therapeutic market in 2025. The regions covered in the arthritic therapeutic market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Arthritic Therapeutic Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=19297&type=smp

Browse Through More Reports Similar to the Global Arthritic Therapeutic Market 2026, By The Business Research Company

Mantle Cell Lymphoma Therapeutics Market Report 2026

https://www.thebusinessresearchcompany.com/report/mantle-cell-lymphoma-therapeutics-global-market-report

Glycomic Therapeutics Market Report 2026

https://www.thebusinessresearchcompany.com/report/glycomic-therapeutics-global-market-report

Pruritus Therapeutics Market Report 2026

https://www.thebusinessresearchcompany.com/report/pruritus-therapeutics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795